Overview and Basis of Presentation (Details) - USD ($) $ in Millions |
1 Months Ended | 3 Months Ended | |
|---|---|---|---|
Mar. 31, 2021 |
May 31, 2024 |
Jun. 30, 2026 |
|
| Disposal Group, Including Discontinued Operations [Line Items] | |||
| Cash, cash equivalents, and marketable securities | $ 1,000.0 | ||
| Vorasidenib | Contingent Payments and Royalty Rights | |||
| Disposal Group, Including Discontinued Operations [Line Items] | |||
| Sale of royalty interests, percentage sold | 100.00% | ||
| Milestone payment for achievement of specified ex-U.S. commercial milestone event | $ 1,000.0 | ||
| Royalty percent for sales over $1 billion (as a percent) | 12.00% | ||
| Percentage of royalty rights retained | 3.00% | ||
| Oscotec Inc. | |||
| Disposal Group, Including Discontinued Operations [Line Items] | |||
| Upfront payment | 25.0 | ||
| Contingent consideration | $ 140.0 | ||
| Discontinued Operations, Disposed of by Sale | Vorasidenib | United States | Agios Oncology Business | |||
| Disposal Group, Including Discontinued Operations [Line Items] | |||
| Contingent royalty payment | 15.00% |
| X | ||||||||||
- Definition Gain Contingency, Royalty Percentage Of Net Sales No definition available.
|
| X | ||||||||||
- Definition Percentage Of Royalty Rights Retained No definition available.
|
| X | ||||||||||
- Definition Portion Of Potential Milestone Payment Receivable For Filing Of New Drug Application No definition available.
|
| X | ||||||||||
- Definition Royalty Percentage Over One Billion Dollars No definition available.
|
| X | ||||||||||
- Definition Sale Of Royalty Interests, Percentage Sold No definition available.
|
| X | ||||||||||
- Definition Amount of contingent consideration recognized as part of consideration transferred in asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|